Moore KD - Search Results

1

Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding.

Lewis DA, Moore KD, Ortel TL. Lewis DA, et al. Among authors: moore kd. Blood Coagul Fibrinolysis. 2003 Jun;14(4):361-8. doi: 10.1097/00001721-200306000-00007. Blood Coagul Fibrinolysis. 2003. PMID: 12945878

2

Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIII.

Ortel TL, Moore KD, Ezban M, Kane WH. Ortel TL, et al. Among authors: moore kd. Thromb Haemost. 1996 Jan;75(1):36-44. Thromb Haemost. 1996. PMID: 8713777

3

Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.

Ortel TL, Moore KD, Quinn-Allen MA, Okamura T, Sinclair AJ, Lazarchick J, Govindan R, Carmagnol F, Kane WH. Ortel TL, et al. Among authors: moore kd. Blood. 1998 Jun 1;91(11):4188-96. Blood. 1998. PMID: 9596666 Free article.

4

Factor VIII Arg2304 --> His binds to phosphatidylserine and is a functional cofactor in the factor X-ase complex.

Lewis DA, Moore KD, Ortel TL. Lewis DA, et al. Among authors: moore kd. Thromb Haemost. 2001 Feb;85(2):260-4. Thromb Haemost. 2001. PMID: 11246544

5

Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.

Ortel TL, James AH, Thames EH, Moore KD, Greenberg CS. Ortel TL, et al. Among authors: moore kd. Thromb Haemost. 2000 Jul;84(1):93-7. Thromb Haemost. 2000. PMID: 10928477

6

Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Ortel TL, et al. Among authors: moore kd. Ann Surg. 2001 Jan;233(1):88-96. doi: 10.1097/00000658-200101000-00014. Ann Surg. 2001. PMID: 11141230 Free PMC article.

7

Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa.

Hansen KE, Moore KD, Ortel TL, Allen NB. Hansen KE, et al. Among authors: moore kd. Arthritis Rheum. 1999 Oct;42(10):2250-2. doi: 10.1002/1529-0131(199910)42:10<2250::AID-ANR32>3.0.CO;2-7. Arthritis Rheum. 1999. PMID: 10524702 Free article. No abstract available.

8

Risk factors associated with thrombosis in patients with antiphospholipid antibodies.

Hansen KE, Kong DF, Moore KD, Ortel TL. Hansen KE, et al. Among authors: moore kd. J Rheumatol. 2001 Sep;28(9):2018-24. J Rheumatol. 2001. PMID: 11550969

9

Antibodies to prothrombin, factor V, and beta2-glycoprotein I and vascular access thrombosis.

Sands JJ, Nudo SA, Moore KD, Ortel TL. Sands JJ, et al. Among authors: moore kd. ASAIO J. 2001 Sep-Oct;47(5):507-10. doi: 10.1097/00002480-200109000-00022. ASAIO J. 2001. PMID: 11575827

10

Antibodies to topical bovine thrombin correlate with access thrombosis.

Sands JJ, Nudo SA, Ashford RG, Moore KD, Ortel TL. Sands JJ, et al. Among authors: moore kd. Am J Kidney Dis. 2000 May;35(5):796-801. doi: 10.1016/s0272-6386(00)70247-2. Am J Kidney Dis. 2000. PMID: 10793011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters